News
$Adaptimmune Therapeutics(ADAP.US$ Reg-Galapagos and Adaptimmune Sign Clinical Collaboration Agreement With an Option to Exclusively License Adaptimmune’s Tcr T-Cell Therapy Candidate, Uza-Cel, in Head & Neck Cancer and Potential Future Solid Tumor Indications! To receive 100 million upfront payments
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
JMTRUSTFUND : I could use some up front payments also....
TrytosaveabitOP JMTRUSTFUND: Hehehe! You and me both! GL